| • |
Closing Glance: Biotechnology (AP via Yahoo! Finance) |
| | Shares of biotechnology companies closed mixed Friday as the broader market tumbled over wider-than-expected losses at insurer American International Group Inc. and a spike in oil prices. |
| | Published Date : Fri, 09 May 2008 20:39:57 GMT |
| |
| • |
Opening Glance: Biotechnology shares open lower (AP via Yahoo! Finance) |
| | Shares of biotechnology companies opened lower Friday as the broader market tumbled over wider-than-expected losses at insurer American International Group Inc. and a spike in oil prices. |
| | Published Date : Fri, 09 May 2008 14:05:22 GMT |
| |
| • |
Closing Glance: Biotechnology stocks mostly rise (AP via Yahoo! Finance) |
| | Shares of biotechnology companies closed mostly higher Thursday as the broader market rose on reports of better-than-expected April retail sales. |
| | Published Date : Thu, 08 May 2008 20:32:35 GMT |
| |
| • |
Scotland aims to lead in biotechnology with new life sciences institute (PublicTechnology.net) |
| | Scotland's position as an international leader in the biotechnology field is to be strengthened further with the creation of a £10 million national life sciences institute in Dundee. |
| | Published Date : Fri, 09 May 2008 06:16:49 GMT |
| |
| • |
Dept of Biotechnology to spend Rs 350 cr for PPP projects in futuristic technologies (PharmaBiz) |
| | About Rs 350 crore will be spent during the 11th Five Year Plan period under the Biotechnology Industry Partnership Programme (BIPP) by the Department of Biotechnology to accelerate the development of futuristic technologies in areas like vaccine manufacturing through public-private partnerships. |
| | Published Date : Fri, 09 May 2008 02:39:57 GMT |
| |
| • |
Enzon to spin off biotechnology business (Pharmaceutical Business Review) |
| | Enzon Pharmaceuticals has authorized a plan to spin-off its novel biotechnology business from the company in a transaction that will result in two independent and highly focused public companies. |
| | Published Date : Fri, 09 May 2008 01:26:19 GMT |
| |
| • |
InNexus Biotechnology Hosts Inaugural Event of U.S. Department of Commerce (Centre Daily Times) |
| | InNexus Biotechnology Inc. (OTCBB:IXSBF) (TSX VENTURE:IXS) (http://www.ixsbio.com), a drug development company commercializing the next generation of monoclonal antibodies based on its Dynamic Cross Linking (DXL(TM)) technology, yesterday hosted the U.S. Department of Commerce Invest in America event sponsored by the Greater Phoenix Economic Council at InNexus' facilities located on the Campus ... |
| | Published Date : Thu, 08 May 2008 13:26:31 GMT |
| |
| • |
Biotechnology must become plat principal (European Voice) |
| | A chat over breakfast hardly matches the urgent needs of a hungry world. The European Commission's breakfast review of Europe's biotechnology regulation yesterday (7 May)scarcely did justice to the subject. |
| | Published Date : Thu, 08 May 2008 10:02:34 GMT |
| |
| • |
InNexus Biotechnology Hosts Inaugural Event of U.S. Department of Commerce (Business Wire via Yahoo! Finance) |
| | BRITISH COLUMBIA, Canada----InNexus Biotechnology Inc. , a drug development company commercializing the next generation of monoclonal antibodies based on its Dynamic Cross Linking technology, yesterday hosted the U.S. |
| | Published Date : Thu, 08 May 2008 13:00:00 GMT |
| |
| • |
Analysis: Biotech sees Mass. lawmakers as friends, foes (AP via Yahoo! Finance) |
| | Gov. Deval Patrick, House Speaker Salvatore DiMasi and Senate President Therese Murray are taking a road trip to San Diego next month for a major biotechnology conference. The way things are shaping up, they could end up as the proverbial skunks at a lawn party. |
| | Published Date : Fri, 09 May 2008 20:36:08 GMT |
| |
